Topical Placebo Cream

DRUG5 trials

Sponsors

Imprimis Pharmaceuticals, Inc., Dipexium Pharmaceuticals, Inc., Amazentis SA

Conditions

Acute Soft Tissue InjuryDiabetic Foot InfectionErythemaSkin AgingSkin InflammationSprainStrainSun Damaged Skin

Phase 3

Ketoprofen 10% Cream for Treatment of Pain Associated With Mild to Moderate Acute Soft Tissue Injury

CompletedNCT00765700

Imprimis Pharmaceuticals, Inc.Acute Soft Tissue Injury, Sprain, Strain

Start: 2008-09-30End: 2009-09-30Updated: 2013-09-27

Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers

CompletedNCT01590758

Dipexium Pharmaceuticals, Inc.Diabetic Foot Infection

Start: 2014-06-30End: 2016-08-31Updated: 2017-06-14

Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers

CompletedNCT01594762

Dipexium Pharmaceuticals, Inc.Diabetic Foot Infection

Start: 2014-06-30End: 2016-07-31Updated: 2017-06-14

Unknown Phase

Evaluation of the Anti-aging Efficacy of a Novel Skin Health Product

CompletedNCT05300984

Amazentis SASkin Aging

Start: 2022-03-15End: 2022-05-16Updated: 2023-04-06

Efficacy Study of a Novel Skin Health Product to Reduce an UVB Induced Erythema

CompletedNCT05300542

Amazentis SAErythema, Skin Inflammation, Sun Damaged Skin

Start: 2022-03-17End: 2022-04-13Updated: 2023-04-06

Related Papers

Rational design of stapled antimicrobial peptides.

2023-02-1228 citations

A randomized, controlled study to investigate the efficacy and safety of a topical gentamicin-collagen sponge in combination with systemic antibiotic therapy in diabetic patients with a moderate or severe foot ulcer infection.

2018-08-0238 citations